Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-20-006625

Options or other derivatives

  • Exec VP, Comm Optns acquired 379,947 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BOYER ANDREW S Exec VP, Comm Optns 2020-02-27 Grant or award · Restricted Stock Units +126,649 126,649 D
BOYER ANDREW S Exec VP, Comm Optns 2020-02-27 Grant or award · Performance-Based Restricted Stock Units +253,298 253,298 D
Loading xslF345X03/doc4.xml…